Wall Street loves a shiny object. Tell the Street that a digital platform can fix back pain through an app and a sensor, slap a high-growth SaaS multiple on it, and the analysts start hyperventilating. Jim Cramer hears "digital musculoskeletal care" and reaches for the button. Buy, buy, buy.
It is a lazy consensus. It is a bet built on a fundamental misunderstanding of how human biology and enterprise cost structures actually collide.
I have watched corporate benefits buyers blow millions on digital physical therapy point solutions that promise the moon and deliver a three percent utilization rate. The pitch sounds brilliant in a slide deck. Employees with aching lower backs strap on a Bluetooth IMU sensor, follow animated exercises on a tablet, and magically avoid expensive orthopedic surgeries. Healthcare costs plummet. Productivity surges.
Except human behavior does not bend to the will of venture-backed software.
Musculoskeletal conditions cost American employers billions. That part is true. But throwing an app at a degenerative disc or a chronic knee issue is like trying to fix a blown car engine with a smartphone wallpaper app. Pain is complex. It is biological, psychological, and social. It requires high-touch clinical judgment, not a gamified streak counter on an iPhone.
The Engagement Mirage
Let us look at the core metric the bulls ignore: actual, sustained engagement.
Most point solutions in the digital health space brag about high net promoter scores from the five percent of the employee population that is already motivated, health-conscious, and prone to using wellness benefits. What about the other ninety-five percent? The truck driver with sciatica? The warehouse worker whose back is shot after a ten-hour shift? They do not want another app notification telling them to log their stretches. They want real relief, or at least an honest diagnosis from someone who can touch their spine.
When a company buys into Hinge Health, they are buying a distribution funnel wrapped in clinical marketing. They are paying for heavy customer acquisition costs disguised as enterprise contracts. The retention curve for consumer and employee wellness apps is brutal. Users drop off a cliff after week three. The novelty wears off, the sensor ends up in a junk drawer next to the old fitness tracker, and the employer is left holding a recurring subscription bill for an empty digital ghost town.
I have sat across the table from chief human resources officers who realized too late that they bought a subscription their employees stopped opening thirty days after the launch email went out. The vendor points to clinical trials showing pain reduction. Naturally, the people who actually stick with a physical therapy program get better. That is how physical therapy works, whether you use a rubber band from a clinic or a sensor linked to an iPad. The software is not the active ingredient. The movement is. And you do not need a billion-dollar valuation to tell people to move.
Why the Unit Economics Fail Under Scrutiny
Look past the revenue growth numbers. What are the unit economics when you factor in chronic disease complexity?
Musculoskeletal care is not like expense management software or payroll processing. You cannot automate physical rehabilitation for complex, multi-morbid populations. When an employee has severe spinal stenosis or a torn meniscus, an app is not just useless; it is a liability.
Companies deploying these tools often find themselves trapped in a cycle of redundancy. Employees still need traditional orthopedic visits, MRIs, injections, and surgery. The digital platform sits on top of the existing health plan as a marginal cost center rather than a true replacement. You are not bending the cost curve. You are adding an extra layer of software bloat to an already bloated healthcare supply chain.
Venture capitalists love these models because they scale infinitely with zero marginal cost of software delivery. But healthcare delivery does not scale like software. It requires humans. The moment you introduce human physical therapists to review data, manage escalations, and handle patient outreach, your gross margins start to look suspiciously like a traditional clinic chain, just with a much higher burn rate.
The Alternative Nobody Wants to Fund
If you want to fix workplace musculoskeletal spend, stop looking at Silicon Valley. Look at what actually works in the trenches.
The companies winning at this game are not the ones spending tens of millions on glossy enterprise marketing campaigns. They are the ones embedding high-quality, physical musculoskeletal triage directly into primary care, or partnering with localized orthopedic practices that have skin in the game. They use targeted interventions, direct-to-employer direct primary care networks, and old-fashioned accountability.
It is not sexy. You cannot slap a trendy logo on it and pitch it on a financial news segment. It requires hard operational grit.
Wall Street wants a simple narrative. They want to believe that a software wrapper can solve a structural healthcare crisis. It cannot.
Take a hard look at the balance sheets, look at the real-world utilization data, and stop confusing software distribution with clinical efficacy.
The next time someone tells you to buy a digital MSK stock, ask them what happens to the utilization rate on day one hundred and eighty. Watch how fast the conversation changes.
